BIOTECHNOLOGY ASSETS, S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.34 EUR | -2.58% |
|
-1.45% | -14.14% |
| 05/04 | Biotechnology Assets, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Biotechnology Assets, S.A. Auditor Raises 'Going Concern' Doubt | CI |
| Sales 2022 | 2.96M 3.17M 264M | Sales 2023 | 3.91M 4.18M 349M | Capitalization | 22.85M 24.46M 2.04B |
|---|---|---|---|---|---|
| Net income 2022 | -1M -1.07M -89.35M | Net income 2023 | 1M 1.07M 89.35M | EV / Sales 2022 | 6.72 x |
| Net Debt 2022 | 7.45M 7.97M 665M | Net Debt 2023 | 3.72M 3.98M 332M | EV / Sales 2023 | 6.8 x |
| P/E ratio 2022 |
-6.41
x | P/E ratio 2023 |
14.5
x | Employees | 37 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.46% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -2.58% | ||
| 1 week | -1.45% | ||
| Current month | -8.85% | ||
| 1 month | -8.85% | ||
| 3 months | -16.05% | ||
| 6 months | -17.07% | ||
| Current year | -14.14% |
1 week
0.34
0.37
1 month
0.320.39
Current year
0.320.46
1 year
0.300.50
3 years
0.091.02
5 years
0.092.50
10 years
0.092.64
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 60 | 01/19/01 | |
Javier Uría
COO | Chief Operating Officer | - | - |
| Chief Tech/Sci/R&D Officer | - | 01/07/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
John Dixon
BRD | Director/Board Member | 68 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 0.34 | -2.58% | 58,354 |
| 26/24/26 | 0.349 | -1.69% | 30,704 |
| 25/24/25 | 0.355 | -0.70% | 62,651 |
| 24/24/24 | 0.3575 | +3.92% | 248,365 |
| 23/24/23 | 0.344 | -0.29% | 39,548 |
Delayed Quote BME, April 29, 2024 at 09:05 pm IST
More quotes
Biotechnology Assets SA, formerly known as ADL Bionatur Solutions SA, is a Spain-based biotech company. The Firmâs main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.14% | 21.03M | |
| -2.63% | 102B | |
| +1.62% | 96.29B | |
| +2.15% | 22.18B | |
| -16.67% | 21.2B | |
| -8.58% | 18.31B | |
| -38.74% | 17.38B | |
| -13.21% | 16.36B | |
| +5.41% | 13.97B | |
| +33.57% | 12.17B |
- Stock Market
- Equities
- BST Stock
